Pfizer-Allergan Won't Be the Last Inversion
November 23, 2015 at 12:26 PM EST
Despite the potential political backlash facing companies seeking to avoid paying U.S. taxes, analysts believe the practice will continue.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.